Companies › Eli Lilly › Net income

Eli Lilly net income, 2008–2025

Eli Lilly reported net income of $20.6 billion for the fiscal year ended Dec. 31, 2025, up 94.9% from $10.6 billion the year before, according to its Form 10-K.

$20.6Blatest fiscal year (ended Dec. 31, 2025)
+94.9%change from the year before
$20.6Bhighest year shown (2025)
2008: −$2.07B ’08 2009: $4.33B 2010: $5.07B ’10 2011: $4.35B 2012: $4.09B ’12 2013: $4.68B 2014: $2.39B ’14 2015: $2.41B 2016: $2.74B ’16 2017: −$204.1M 2018: $3.23B ’18 2019: $8.32B 2020: $6.19B ’20 2021: $5.58B 2022: $6.24B ’22 2023: $5.24B 2024: $10.6B ’24 2025: $20.6B ’25

Fiscal years labeled by the year in which they ended. Bars drawn from the table below.

Eli Lilly net income by fiscal year

Fiscal year endedNet incomeChangeFiling
Dec. 31, 2025 $20.6B +94.9% 10-K (2026) ↗
Dec. 31, 2024 $10.6B +102.1% 10-K (2026) ↗
Dec. 31, 2023 $5.24B −16.1% 10-K (2026) ↗
Dec. 31, 2022 $6.24B +11.9% 10-K (2025) ↗
Dec. 31, 2021 $5.58B −9.9% 10-K (2024) ↗
Dec. 31, 2020 $6.19B −25.5% 10-K (2023) ↗
Dec. 31, 2019 $8.32B +157.4% 10-K (2022) ↗
Dec. 31, 2018 $3.23B — 10-K (2021) ↗
Dec. 31, 2017 −$204.1M −107.5% 10-K (2020) ↗
Dec. 31, 2016 $2.74B +13.7% 10-K (2019) ↗
Dec. 31, 2015 $2.41B +0.7% 10-K (2018) ↗
Dec. 31, 2014 $2.39B −49.0% 10-K (2017) ↗
Dec. 31, 2013 $4.68B +14.6% 10-K (2016) ↗
Dec. 31, 2012 $4.09B −6.0% 10-K (2015) ↗
Dec. 31, 2011 $4.35B −14.2% 10-K (2014) ↗
Dec. 31, 2010 $5.07B +17.1% 10-K (2013) ↗
Dec. 31, 2009 $4.33B — 10-K (2012) ↗
Dec. 31, 2008 −$2.07B — 10-K (2011) ↗

Other Eli Lilly financials

RevenueDiluted EPSR&D expenseOperating cash flowDividends per shareDiluted sharesTotal assetsCash and equivalentsStockholders' equity Quarterly results and next earnings date Eli Lilly company hub

FAQ

Q What was Eli Lilly's net income in its latest fiscal year?

A Eli Lilly reported net income of $20.6 billion for the fiscal year ended Dec. 31, 2025, up 94.9% from $10.6 billion the year before, according to its Form 10-K.

Q What is Eli Lilly's highest annual net income on record here?

A $20.6 billion, in the fiscal year ended Dec. 31, 2025, among the fiscal years 2008–2025 reported in its 10-K XBRL data.

Q Where does this net income data come from?

A From Eli Lilly's annual reports on Form 10-K, as tagged in XBRL and published by the SEC (company facts). Net income (loss) as reported, before any adjustments the company presents separately.

Source: Eli Lilly's annual reports on Form 10-K via SEC XBRL company facts, updated Oct. 15, 2026. Net income (loss) as reported, before any adjustments the company presents separately. For each year the most recent 10-K that reports it is used, so a figure a company later restated shows the restated value; the filing link shows which report it came from. Change is our arithmetic. Financial data, not investment advice.